EP1796610A4 - TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE - Google Patents

TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE

Info

Publication number
EP1796610A4
EP1796610A4 EP05802679A EP05802679A EP1796610A4 EP 1796610 A4 EP1796610 A4 EP 1796610A4 EP 05802679 A EP05802679 A EP 05802679A EP 05802679 A EP05802679 A EP 05802679A EP 1796610 A4 EP1796610 A4 EP 1796610A4
Authority
EP
European Patent Office
Prior art keywords
therapeutic system
transdermal therapeutic
parkinson disease
parkinson
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05802679A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1796610A2 (en
Inventor
Marina Braun
Willi Cawello
Eric B Foster
Thomas Lauterbach
Hans-Michael Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Inc
Original Assignee
Schwarz Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwarz Pharma Inc filed Critical Schwarz Pharma Inc
Publication of EP1796610A2 publication Critical patent/EP1796610A2/en
Publication of EP1796610A4 publication Critical patent/EP1796610A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP05802679A 2004-09-29 2005-09-29 TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE Withdrawn EP1796610A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61376104P 2004-09-29 2004-09-29
US61376004P 2004-09-29 2004-09-29
PCT/US2005/035257 WO2006039532A2 (en) 2004-09-29 2005-09-29 Transdermal therapeutic system for parkinson’s disease

Publications (2)

Publication Number Publication Date
EP1796610A2 EP1796610A2 (en) 2007-06-20
EP1796610A4 true EP1796610A4 (en) 2012-12-05

Family

ID=36143101

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05802679A Withdrawn EP1796610A4 (en) 2004-09-29 2005-09-29 TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE

Country Status (3)

Country Link
EP (1) EP1796610A4 (enExample)
JP (1) JP2008514376A (enExample)
WO (1) WO2006039532A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EP3111935A4 (en) 2014-02-27 2017-03-15 Medrx Co., Ltd. Pramipexole-containing transdermal patch for treatment of neurodegenerative disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049852A1 (de) * 1998-03-30 1999-10-07 Lts Lohmann Therapie-Systeme Ag D2-agonist enthaltendes transdermales therapeutisches system zur behandlung des parkinson-syndroms und verfahren zu seiner herstellung
EP1325742A1 (en) * 2001-05-08 2003-07-09 Schwarz Pharma Ag Improved transdermal therapeutic system for the treatment of Parkinson's disease
EP1344522A1 (en) * 2001-05-08 2003-09-17 Schwarz Pharma Ag Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
EP1386605A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885308A (en) * 1984-08-13 1989-12-05 Nelson Research & Development Co. Method and compositions for treatment of parkinsonism syndrome in mammals
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
US6448303B1 (en) * 2000-12-29 2002-09-10 National Starch And Chemical Investment Holding Corporation Hot melt adhesives for dermal application
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049852A1 (de) * 1998-03-30 1999-10-07 Lts Lohmann Therapie-Systeme Ag D2-agonist enthaltendes transdermales therapeutisches system zur behandlung des parkinson-syndroms und verfahren zu seiner herstellung
EP1325742A1 (en) * 2001-05-08 2003-07-09 Schwarz Pharma Ag Improved transdermal therapeutic system for the treatment of Parkinson's disease
EP1344522A1 (en) * 2001-05-08 2003-09-17 Schwarz Pharma Ag Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
EP1386605A1 (en) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine

Also Published As

Publication number Publication date
JP2008514376A (ja) 2008-05-08
WO2006039532A2 (en) 2006-04-13
EP1796610A2 (en) 2007-06-20
WO2006039532A3 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
IL250734A0 (en) Transdermal therapeutic system
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK3457135T3 (da) Behandlingsmuligheder til fabrys sygdom
DK1879623T3 (da) Genterapi til rygmarvssygdomme
EP1868459A4 (en) FUNCTIONAL SHOE
EP2026856A4 (en) Heart assist device
DK2117521T3 (da) Transdermale indgivelsessystemer omfattende bupivacain
DK2144905T3 (da) Terapeutiske midler
DK2035369T3 (da) Terapeutiske
DK1844813T3 (da) Iontoforeseapparat
DK1993589T3 (da) Behandlinger for neurologiske sygdomme
AT500095B1 (de) Transdermales abgabesystem
DE602005005920D1 (de) Befestigungsvorrichtung für Rollstuhl
ATE524168T1 (de) Transdermales system für vareniclin
EP2059297A4 (en) IONTOPHORESIS DEVICE
BRPI0818598A2 (pt) agentes terapêuticos - 802
FR2893278B1 (fr) Maintien lateral alveolaire
ZA200809004B (en) Autodestructive transdermal therapeutic system
DE112006001343A5 (de) Patientenauflage
EP1796610A4 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE
EP2140876A4 (en) THERAPEUTIC AGENT WITH VASOHIBIN
ITVR20050112A1 (it) Lettino per massaggi
DE602005005655D1 (de) Massagebett
DK1934388T3 (da) Fremgangsmåde til lægemiddeludvikling
ATA13282004A (de) Massagegerät

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070502

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: HR MK

RAX Requested extension states of the european patent have changed

Extension state: MK

Payment date: 20070502

Extension state: HR

Payment date: 20070502

A4 Supplementary search report drawn up and despatched

Effective date: 20121105

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 13/02 20060101AFI20121029BHEP

Ipc: A61K 31/381 20060101ALI20121029BHEP

Ipc: A61K 9/70 20060101ALI20121029BHEP

Ipc: A61F 13/00 20060101ALI20121029BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130604